Bruker rescues insolvent Noscendo, buying DISQVER platform after €40M raise fell short
What's the deal? US life-sciences company BrukerDealroom has a profile for this one. Try Dealroom → is acquiring the DISQVER platform and select assets of insolvent German diagnostics startup NoscendoDealroom has a profile for this one. Try Dealroom →. The Duisburg-based company is being restructured through a transferred reorganisation. Financial terms were not disclosed.
What does Noscendo do? Founded in 2016, the startup developed a method to identify pathogens from cell-free DNA using next-generation sequencing. The technique detects pathogens in under 24 hours and is used by university hospitals and clinic groups for sepsis diagnostics. Noscendo also secured selective contracts with health insurers, including Techniker KrankenkasseDealroom has a profile for this one. Try Dealroom →.
Why now? Despite raising nearly €40 million in venture capital, commercialisation moved slower than expected, hampered by delays in selective contracts and financial pressure on clinics. A planned funding round by existing investors collapsed in mid-February 2026, and buyer talks in March led nowhere. Noscendo filed for insolvency over illiquidity and over-indebtedness at the end of March.
The layoffs: Buyers wanted only the patented software, intellectual property, and Duisburg IT and sales staff. That prompted administrator Sarah Wolf to approve a partial shutdown of the Kusterdingen laboratory in April. Bruker takes on select assets and employees; only part of the workforce is preserved.
What they're saying: "Only through this hard strategic cut could the attractiveness of Noscendo's remaining assets be increased for investors," said managing director Andreas Käpplein. Wolf called Bruker "a strong strategic partner" for advancing "this life-saving technology."
Consultancy Centuros Consult advised on the M&A process, while Anchor Rechtsanwälte handled the insolvency proceedings.
The signal: Noscendo shows how strong technology alone rarely saves a startup when the path to market stalls. Even with meaningful venture backing, slow commercialisation and a squeezed customer base can force a distressed sale — with a strategic acquirer stepping in to salvage the core assets and jobs.
Read more: VC Magazin
Image credit: U.S. Department of Energy
